U.S. Venture Partners
U.S. Venture Partners (USVP), founded in 1981 and based in Menlo Park, California, is a venture capital firm that specializes in early-stage investments. The firm focuses on transformative ideas within the information technology and healthcare sectors, emphasizing innovation that drives economic growth and job creation. USVP's investment areas include enterprise software, IT security, consumer internet, mobile applications, e-commerce, healthcare, and IT-enabled healthcare services. The team at USVP comprises former entrepreneurs, technologists, corporate executives, financial professionals, and industry experts, all dedicated to supporting entrepreneurs in their journey to build impactful companies. The firm primarily targets businesses located on the West Coast of the United States, seeking opportunities in B2B, life sciences, oncology, cybersecurity, digital health, and cloud technology.
Past deals in Austin, TX
MicroTransponder
Series F in 2025
MicroTransponder, Inc. is a medical device company based in Austin, Texas, specializing in the development and commercialization of neurostimulation devices aimed at treating various neurological diseases. Founded in 2007, the company focuses on therapies that utilize vagus nerve stimulation (VNS) to address conditions such as tinnitus, chronic pain, and rehabilitation for stroke survivors. Its notable products include the Serenity System, designed specifically for tinnitus treatment, and the Vivistim device, which is FDA approved for assisting ischemic stroke survivors with moderate to severe upper limb impairment. Through its innovative approaches, MicroTransponder aims to enhance recovery and improve the quality of life for individuals affected by these neurological conditions.
MicroTransponder
Series E in 2022
MicroTransponder, Inc. is a medical device company based in Austin, Texas, specializing in the development and commercialization of neurostimulation devices aimed at treating various neurological diseases. Founded in 2007, the company focuses on therapies that utilize vagus nerve stimulation (VNS) to address conditions such as tinnitus, chronic pain, and rehabilitation for stroke survivors. Its notable products include the Serenity System, designed specifically for tinnitus treatment, and the Vivistim device, which is FDA approved for assisting ischemic stroke survivors with moderate to severe upper limb impairment. Through its innovative approaches, MicroTransponder aims to enhance recovery and improve the quality of life for individuals affected by these neurological conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.